Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan.

J Cancer · 2014 · PMC4067509 · PMID 24963354

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

almost significantlyP =0.053so close (0.05 < p ≤ 0.1)

The proportion of male patients in the aged group was almost significantly lower than that in the control group ( P =0.053).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.